Yu Qingming, party chief and chairman of Sinopharm, told Chinese state media on March 4 that he and others at the firm’s management received CCP (Chinese Communist Party) virus vaccines a year ago and still have a high level of antibodies. His claim ignited a heated discussion over the origins of the virus strains and the timeline of China’s vaccine development.
Sinopharm is also known as China National Pharmaceutical Group Corporation, a Beijing-based Chinese state-owned enterprise.
